Search Results

There are 32401 results for: content related to: Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients

  1. You have free access to this content
    Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy

    BJU International

    Volume 111, Issue 6, May 2013, Pages: 928–933, Atsushi Ochiai, Koji Okihara, Kazumi Kamoi, Takehiro Oikawa, Toru Shimazui, Shin-Ichiro Murayama, Kyoichi Tomita, Tohru Umekawa, Hirotsugu Uemura and Tsuneharu Miki

    Version of Record online : 18 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11683.x

  2. You have free access to this content
    From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

    BJU International

    Volume 112, Issue 6, October 2013, Pages: 717–728, Satoshi Hori, Jean-Sebastien Blanchet and John McLoughlin

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1464-410X.2012.11329.x

  3. You have free access to this content
    Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial

    BJU International

    Volume 111, Issue 6, May 2013, Pages: 988–996, Guillaume Ploussard, Nathalie Nicolaiew, Charles Marchand, Stéphane Terry, Yves Allory, Francis Vacherot, Claude-Clément Abbou, Laurent Salomon and Alexandre de la Taille

    Version of Record online : 4 MAR 2013, DOI: 10.1111/j.1464-410X.2012.11607.x

  4. You have free access to this content
    Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density

    BJU International

    Volume 113, Issue 4, April 2014, Pages: 561–567, Martin H. Umbehr, Elizabeth A. Platz, Sarah B. Peskoe, Nrupen A. Bhavsar, Jonathan I. Epstein, Patricia Landis, Alan W. Partin and H. Ballentine Carter

    Version of Record online : 7 JUN 2013, DOI: 10.1111/bju.12131

  5. You have free access to this content
    Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E653–E657, Eliney Ferreira Faria, Gustavo F. Carvalhal, Rodolfo Borges dos Reis, Marcos Tobias-Machado, Renê A.C. Vieira, Leonardo O. Reis, Lucas Nogueira, Roberto Dias Machado, Celso H. Freitas Jr, Wesley J. Magnabosco, Edmundo C. Mauad and André Lopes Carvalho

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11398.x

  6. You have free access to this content
    Landmarks in prostate cancer diagnosis: the biomarkers

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 8–13, Walter Artibani

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.011429.x

  7. You have free access to this content
    Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E98–E105, Frederik Birkebæk Thomsen, Ib Jarle Christensen, Klaus Brasso, Martin Andreas Røder and Peter Iversen

    Version of Record online : 31 OCT 2013, DOI: 10.1111/bju.12367

  8. You have free access to this content
    The percentage of prostate-specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

    BJU International

    Volume 117, Issue 1, January 2016, Pages: 72–79, Martin Boegemann, Carsten Stephan, Henning Cammann, Sébastien Vincendeau, Alain Houlgatte, Klaus Jung, Jean-Sebastien Blanchet and Axel Semjonow

    Version of Record online : 24 MAY 2015, DOI: 10.1111/bju.13139

  9. You have free access to this content
    Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials

    BJU International

    Volume 117, Issue S4, April 2016, Pages: 17–34, Margaret Diana van Die, Kerry M. Bone, Jon Emery, Scott G. Williams, Marie V. Pirotta and Channing J. Paller

    Version of Record online : 22 FEB 2016, DOI: 10.1111/bju.13361

  10. You have free access to this content
    The utility of prostate-specific antigen in the management of advanced prostate cancer

    BJU International

    Volume 112, Issue 5, September 2013, Pages: 548–560, E. David Crawford, Charles L. Bennett, Gerald L. Andriole, Marc B. Garnick and Daniel P. Petrylak

    Version of Record online : 4 JUL 2013, DOI: 10.1111/bju.12061

  11. You have free access to this content
    Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA

    BJU International

    Volume 107, Issue 10, May 2011, Pages: 1576–1581, Flavio L. Heldwein, Patrick E. Teloken, Antonio A. Hartmann, Ernani L. Rhoden and Claudio Teloken

    Version of Record online : 18 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09948.x

  12. You have free access to this content
    Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy

    International Journal of Urology

    Volume 16, Issue 6, June 2009, Pages: 561–565, Mai Miyakubo, Kazuto Ito, Takumi Yamamoto, Hiroyuki Takechi, Masaru Ohi and Kazuhiro Suzuki

    Version of Record online : 12 MAY 2009, DOI: 10.1111/j.1442-2042.2009.02304.x

  13. You have free access to this content
    Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project

    BJU International

    Volume 112, Issue 3, August 2013, Pages: 313–321, Massimo Lazzeri, Alexander Haese, Alberto Abrate, Alexandre de la Taille, Joan Palou Redorta, Thomas McNicholas, Giovanni Lughezzani, Giuliana Lista, Alessandro Larcher, Vittorio Bini, Andrea Cestari, Nicolòmaria Buffi, Markus Graefen, Olivier Bosset, Philippe Le Corvoisier, Alberto Breda, Pablo de la Torre, Linda Fowler, Jacques Roux and Giorgio Guazzoni

    Version of Record online : 4 JUL 2013, DOI: 10.1111/bju.12217

  14. Equivocal PSA Results and Free Total PSA Ratio

    Challenges in Prostate Cancer, Second Edition

    Bob Djavan, Michael Dobrovits, Michael Marberger, Pages: 63–75, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470755006.ch6

  15. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

    Intervention Review

    The Cochrane Library

    Jae Hung Jung, Jiye Kim, Roderick MacDonald, Balaji Reddy, Myung Ha Kim and Philipp Dahm

    Published Online : 22 NOV 2017, DOI: 10.1002/14651858.CD012615.pub2

  16. You have free access to this content
    Prostate-specific antigen concentration in young men: new estimates and review of the literature

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1627–1635, Siobhan Sutcliffe, Ratna Pakpahan, Lori J. Sokoll, Debra J. Elliott, Remington L. Nevin, Steven B. Cersovsky, Patrick C. Walsh and Elizabeth A. Platz

    Version of Record online : 13 APR 2012, DOI: 10.1111/j.1464-410X.2012.11111.x

  17. You have free access to this content
    New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

    BJU International

    Volume 101, Issue 6, March 2008, Pages: 675–683, Shahrokh F. Shariat, Jose A. Karam, Vitaly Margulis and Pierre I. Karakiewicz

    Version of Record online : 17 OCT 2007, DOI: 10.1111/j.1464-410X.2007.07283.x

  18. You have free access to this content
    Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial

    BJU International

    Volume 112, Issue 6, October 2013, Pages: 735–741, Tytti H. Yli-Hemminki, Marita Laurila, Anssi Auvinen, Liisa Määttänen, Heini Huhtala, Teuvo L.J. Tammela and Paula M. Kujala

    Version of Record online : 7 JUN 2013, DOI: 10.1111/bju.12153

  19. You have free access to this content
    In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?

    BJU International

    Volume 115, Issue 4, April 2015, Pages: 562–570, Simpa S. Salami, Eran Ben-Levi, Oksana Yaskiv, Laura Ryniker, Baris Turkbey, Louis R. Kavoussi, Robert Villani and Ardeshir R. Rastinehad

    Version of Record online : 25 MAR 2015, DOI: 10.1111/bju.12938

  20. You have free access to this content
    Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

    Journal of Andrology

    Volume 24, Issue 3, May-June 2003, Pages: 299–311, Shalender Bhasin, Atam B. Singh, Ricky Phong Mac, Ballentine Carter, Martin I. Lee and Glenn R. Cunningham

    Version of Record online : 2 JAN 2013, DOI: 10.1002/j.1939-4640.2003.tb02676.x